1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. NeoGenomics Acquires Pathline

M&A Deal Summary

NeoGenomics Acquires Pathline

On March 10, 2025, NeoGenomics acquired life science company Pathline

Acquisition Highlights
  • This is NeoGenomics’ 2nd transaction in the Life Science sector.
  • This is NeoGenomics’ 5th transaction in the United States.
  • This is NeoGenomics’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2025-03-10
Target Pathline
Sector Life Science
Buyer(s) NeoGenomics
Deal Type Add-on Acquisition

Target

Pathline

Ramsey, New Jersey, United States
Pathline is a CLIA/CAP/NYS-certified laboratory that serves a long-standing client base of hospitals, cancer centers, and physician practices, with approximately 98% of its revenue coming from customers in the Northeast. It offers a comprehensive suite of subspecialty pathology services, including histopathology, immunohistochemistry, cytology, cytogenetics, flow cytometry, fluorescence in situ hybridization (FISH), and molecular pathology. Pathline was formed in 2009 and is based in Ramsey, New Jersey.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

NeoGenomics

Fort Myers, Florida, United States
Category Company
Founded 2001
Sector Life Science
Employees2,200
Revenue 661M USD (2024)
DESCRIPTION
Entrance to NeoGenomics' headquarters in Fort Myers, Florida.
Entrance to NeoGenomics' headquarters in Fort Myers, Florida.

NeoGenomics is a clinical laboratory that specializes in cancer genetics diagnostic testing. The company’s testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing. NeoGenomics was founded in 2001 and is based in Fort Myers, Florida.

DEAL STATS #
Overall 7 of 7
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 6 of 6
State: New Jersey M&A 1 of 1
Country: United States M&A 5 of 5
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-01 Delf

Wirral, United Kingdom

Delf is a United Kingdom-based manufacturer and supplier of animal hygiene and industrial cleaning products. Delf offers a wide range of animal hygiene and specialty chemical products. Delf is a select member of the Iodine Registration Group (IRG), allowing it to supply Article 95 PVP-iodine and iodine-based biocidal products to the UK and European Union animal hygiene markets. Delf was founded in 1928 and is based in Wirral, United Kingdom.

Buy -
Mergr

Solution for

Product

Company

Legal